TP53 and glioblastoma: Thus, to investigate the impact of APC inactivation on GBM tumorigenesis, we employed a genetically engineered mouse with APC floxp conditional alleles and crossed it with models featuring p53 loss and KrasG12D activation, all facilitated by the GFAP-Cre transgene.